Airsculpt Technologies is trading at $3.23 (-5.69%) after weaker Q2 results and reduced adjusted EBITDA guidance.

  • August 10, 2026, results showed Q2 revenue down 3% year over year to $42.9 million; adjusted EBITDA fell to $4.9 million.
  • Management lowered full-year adjusted EBITDA guidance to $12 million–$14 million and reaffirmed revenue guidance only at its lower end.
  • The earnings disappointment remains the clearest explanation for continued selling pressure on August 17, 2026.